Please use this identifier to cite or link to this item:
Title: Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents [Algoritmo Latino-Americano para tratamento da esclerose múltipla remitente-recorrente utilizando drogas modificadoras da doença]
Author: Finkelsztejn, A.
Gabbai, A.A.
Fragoso, Y.D.
Carra, A.
Macias-Islas, M.A.
Arcega-Revilla, R.
Garcia-Bonitto, J.
Oehninger-Gatti, C.L.
Orozco-Escobar, G.
Tarulla, A.
Vergara, F.
Vizcarra, D.
Issue Date: 2012
Abstract: Objective: It is estimated that circa 50,000 individuals have relapsing-remitting multiple sclerosis in Latin America. European and NorthAmerican algorithms for the treatment of multiple sclerosis do not foresee our regional difficulties and the access of patients to treatment. Methods: The Latin American Multiple Sclerosis Forum is an independent and supra-institutional group of experts that has assessed the latest scientific evidence regarding efficacy and safety of disease-modifying treatments. Accesses to treatment and pharmacovigilance programs for each of the eight countries represented at the Forum were also analyzed. Results: A specific set of guidelines based upon evidence-based recommendations was designed for Latin America. Future perspectives of multiple sclerosis treatment were also discussed. Conclusions: The present paper translated an effort from representatives of eight countries discussing a matter that cannot be adapted to our region directly from purely European and North-American guidelines for treatment.
Appears in Collections:Producción científica UdeG (prueba)

Files in This Item:
There are no files associated with this item.

Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.